Description

DelveInsight’s “Short Bowel Syndrome - Market Insights, Epidemiology and Market Size Forecast-2020” Reports provides an overview of the disease and global market size of the Short Bowel Syndrome for the 7MM (United States, EU5 (France, Germany, Italy, Spain and UK) and Japan). It also includes global historical and forecasted epidemiological data for the diagnosed incident cases of Short Bowel Syndrome from 2010-2020.
Short-bowel syndrome is a disorder clinically defined by malabsorption, diarrhea, steatorrhea, fluid and electrolyte disturbances, and malnutrition.People with short bowel syndrome cannot absorb enough water, vitamins, and other nutrients from food to sustain life. The treatment options are complex and varied. The specific treatment plan may be highly individualized and can include Total Parental Nutrition (TPN) support, which involves use of oral rehydration solutions, parenteral nutrition and enteral nutrition. Gattex (Teduglutide) is currently the first non-surgical treatment for short bowel syndrome (SBS), which is predicted to improve the daily, lives of the patients and is the third approved therapy by USFDA. The drug is going to be the best selling drug worldwide throughout the forecast period.According to DelveInsight, the forecasted patient population of SBS will increaseat a CAGR of 1.17% from 2015 to 2020 and the worldwide SBS market is estimated to be 2.67 billion by 2020.

The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house Forecast model analysis by DelveInsight team of industry experts.

Download Detail Report With Complete TOC at: http://www.marketresearchreports.biz/sample/sample/655834

Scope

Report covers the disease overview including etiology, pathophysiology, symptoms, diagnosis, disease management, and current treatment options.
Marketed information including available prescription drugs, its patent and exclusivity details followed by drug sales till 2018.
The Report also covers the detailed global historical and forecasted epidemiological data covering United States, EU5, Japan and rest of the word from 2010-2020.
It also provides Market size of Short Bowel Syndrome for United States, EU5 and Japan from 2010 and forecasted Market size to 2020

Table of Content

Short Bowel syndrome
Disease overview:
Pathophysiology:
Symptoms of disease:
Etiology of disease
Diagnosis of disease
Treatment of disease
Overview of Marketed drugs
Zorbtive Description
Mechanism of Action
Pharmacokinetics Properties
Marketed Details
United States
Patent Information
Patents Details
NutreStore Description
Mechanism of Action
Pharmacodynamic Properties
Pharmacokinetics Properties
Marketed Details
United States
Gattex Description
Mechanism of Action
Pharmacodynamics Properties
Pharmacokinetics Properties
Marketed Details
United States
Europe
Patent Information
Patent Exclusivity Expiry Assessment United States (US)
Patents Details
Historical and Forecasted sales of marketed molecules in the Global Short Bowel Syndrome Market
Global Epidemiology of Short Bowel Syndrome Forecasted to 2020
Global Market size (2011-2014)
Global Forecasted Market size (2015-2020)
Global Market Size by Geography
Market size of US (2011-2014)
Forecasted Market size of US (2015-2020)

Browse More PressRelease:
http://www.marketresearchreports.biz/pressreleases

About us

MarketResearchReports.biz is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.

Contact
Mr. Nachiket
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-621-2074
Website: http://www.marketresearchreports.biz/
E: [email protected]